Sensorion announces successful €50.5 million financing with participation from leading new and existing European and American life sciences investors
Support from existing investors: Redmile Group, Invus and Sofinnova Partners
Participation of leading investors specialized in the field of life sciences, including among others Aquilo Capital as well as two major investment management companies
The financing will allow the Company to extend its cash horizon until the end of the 2nd quarter of 2025